Key Financial Inc’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$142K Sell
3,872
-4
-0.1% -$190 0.03% 347
2025
Q4
$197K Sell
3,876
-60
-2% -$3.07K 0.04% 288
2025
Q3
$233K Buy
3,936
+4
+0.1% +$234 0.04% 268
2025
Q2
$271K Hold
3,932
0.05% 240
2025
Q1
$273K Hold
3,932
0.06% 222
2024
Q4
$338K Buy
3,932
+60
+2% +$6.49K 0.08% 187
2024
Q3
$461K Hold
3,872
0.1% 162
2024
Q2
$553K Hold
3,872
0.13% 137
2024
Q1
$497K Sell
3,872
-458
-11% -$54.5K 0.13% 138
2023
Q4
$448K Buy
4,330
+340
+9% +$33.6K 0.12% 136
2023
Q3
$363K Hold
3,990
0.12% 141
2023
Q2
$323K Hold
3,990
0.11% 156
2023
Q1
$317K Hold
3,990
0.12% 146
2022
Q4
$199K Hold
3,990
0.09% 165
2022
Q3
$199K Hold
3,990
0.09% 167
2022
Q2
$223K Hold
3,990
0.12% 139
2022
Q1
$222K Hold
3,990
0.11% 149
2021
Q4
$223K Hold
3,990
0.11% 144
2021
Q3
$192K Hold
3,990
0.11% 153
2021
Q2
$185K Hold
3,990
0.1% 160
2021
Q1
$135K Hold
3,990
0.09% 169
2020
Q4
$139K Buy
+3,990
New +$138K 0.1% 152
2020
Q2
Sell
-3,990
Closed -$120K 445
2020
Q1
$120K Buy
+3,990
New +$119K 0.12% 132

Other funds holding NVO

Key Financial Inc's NVO Position: Q1 2026 in Review

Key Financial Inc reduced its Novo Nordisk (NVO) stake by 0.1% in Q1 2026, selling an estimated $190 and leaving 3,872 shares worth $142K. The position accounts for 0.03% of the portfolio, ranked #347.

Key Financial Inc first reported a position in NVO in Q1 2020 and has held it in 23 quarters since. The position peaked at $553K in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Key Financial Inc held 3,872 shares of Novo Nordisk worth $142K as of Q1 2026.
  • Key Financial Inc sold 4 Novo Nordisk shares in Q1 2026, an estimated $190.
  • Novo Nordisk made up 0.03% of Key Financial Inc's portfolio in Q1 2026, its #347 holding.
  • Key Financial Inc first reported a position in Novo Nordisk in Q1 2020 and has held it in 23 quarters since.
  • Key Financial Inc's Novo Nordisk position peaked at $553K in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Key Financial Inc's 13F filing for Q1 2026, filed 24 Apr 2026.